Back to Search
Start Over
Decreasing longitudinal use of glucocorticosteroids in multiple sclerosis.
- Source :
- Multiple Sclerosis & Related Disorders; Oct2018, Vol. 25, p173-174, 2p
- Publication Year :
- 2018
-
Abstract
- Highlights • Glucocorticosteroid (GCS) continuous to decrease in Germany. • Natalizumab utilization decreased with the emergence of additional treatment options. • GCS utilization decreases for both RRMS and SPMS. • The generally observed decrease in relapses per year is confirmed with in the data. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 22110348
- Volume :
- 25
- Database :
- Supplemental Index
- Journal :
- Multiple Sclerosis & Related Disorders
- Publication Type :
- Academic Journal
- Accession number :
- 132689567
- Full Text :
- https://doi.org/10.1016/j.msard.2018.07.040